Novel anticoagulants and the future of anticoagulation-Reference-Cited by-同舟云学术

Novel anticoagulants and the future of anticoagulation

Published:2009-01 Issue: Volume:123 Page:S50-S55
ISSN:0049-3848
Container-title:Thrombosis Research
language:en
Short-container-title:Thrombosis Research

Author:

Garcia David

Publisher

Elsevier BV

Subject

Hematology

Reference22 articles.

1. Rivaroxaban versus enoxaparin for thromboprophylaxis after hip arthroplasty;Eriksson;N Engl J Med,2008

2. Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty;Lassen;N Engl J Med,2008

3. Lassen MR. Data presented in May, 2008 at European Federation of National Associations of Orthopaedics and Traumatology Congress. Abstract available online at: http://www.efort.org/cdrom2008/F3.pdf [accessed November 17, 2008].

4. Extended duration rivaroxaban versus short-term enoxaparin for the prevention of venous thromboembolism after total hip arthroplasty: A doubleblind, randomised controlled trial;Kakkar;Lancet,2008

5. A dose-ranging study evaluating once-daily oral administration of the factor Xa inhibitor rivaroxaban in the treatment of patients with acute symptomatic deep vein thrombosis. The Einstein-DVT dose-ranging study;Buller;Blood,2008

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anticoagulantes orais diretos para o tratamento da trombose venosa profunda: revisão de revisões sistemáticas;Jornal Vascular Brasileiro;2018-12

2. Pentasaccharides for the treatment of deep vein thrombosis;Cochrane Database of Systematic Reviews;2017-12-02

3. Use of Vitamins K antagonists in non-valvular atrial fibrillation thromboembolic risk prevention in Burkina Faso;Pan African Medical Journal;2016

4. Pentasaccharides for the treatment of deep vein thrombosis;Cochrane Database of Systematic Reviews;2015-07-02

5. Structural characterization of coagulant Moringa oleifera Lectin and its effect on hemostatic parameters;International Journal of Biological Macromolecules;2013-07